← The Wire
ORMPNasdaq
ORAMED PHARMACEUTICALS INC.
Pharmaceutical Preparations · DE · CIK 1176309
The company focuses on research and development of proprietary products and technologies
$158M
Market cap
$4.64
Last close
-0.6%
1D
+15.7%
5D
371K
Volume
Price · last 39 sessions+18.1%
May 4L $3.60 · H $5.00Jun 29
397
Total filings
May 19, 2026
Last filing
12/31
Fiscal year end
10-QQUARTERLY REPORTMay 19, 20268-KMaterial Agreement · Acquisition / DispositionMar 31, 202610-KANNUAL REPORTMar 26, 20268-KMaterial AgreementFeb 20, 20268-KMaterial Agreement · Company UpdateJan 14, 20268-KCompany UpdateJan 7, 20268-KExecutive ChangeDec 31, 20258-KCompany UpdateDec 31, 20258-KResults of OperationsNov 17, 20258-KMaterial Agreement · Security-Holder RightsNov 17, 202510-QQUARTERLY REPORTNov 13, 20258-KMaterial Agreement · Agreement TerminatedOct 24, 20258-KCompany UpdateOct 6, 20258-KExecutive Change · Shareholder VoteAug 21, 202510-QQUARTERLY REPORTAug 14, 20258-KMaterial Agreement · Company UpdateJul 23, 2025DEF 14APROXY STATEMENTJul 16, 202510-K/AAMENDMENT NO. 1 TO FORM 10-KJul 16, 20258-KCompany UpdateMay 21, 202510-QQUARTERLY REPORTMay 15, 20258-KMaterial Agreement · Reg FD DisclosureApr 28, 202510-KANNUAL REPORTMar 27, 20258-KMaterial AgreementMar 3, 20258-KMaterial AgreementFeb 27, 20258-KMaterial Agreement · Reg FD DisclosureFeb 11, 20258-KMaterial AgreementJan 22, 20258-KMaterial AgreementJan 3, 20258-KCompany UpdateDec 17, 202410-QQUARTERLY REPORTNov 7, 20248-KCompany UpdateOct 29, 20248-KMaterial Agreement · Reg FD DisclosureOct 8, 20248-KMaterial AgreementSep 26, 20248-KCompany UpdateSep 23, 2024SC 13GSC 13GSep 16, 202410-QQUARTERLY REPORTAug 14, 20248-KShareholder VoteAug 2, 20248-KCompany UpdateJun 26, 20248-KCompany UpdateJun 24, 2024DEF 14ADEFINITIVE PROXY STATEMENTJun 20, 20248-KExecutive ChangeJun 10, 20248-KExecutive ChangeMay 13, 202410-QQUARTERLY REPORTMay 9, 20248-KCompany UpdateMay 6, 2024SC 13DSCHEDULE 13DMar 22, 20248-KCompany UpdateMar 19, 20248-KExecutive ChangeMar 18, 20248-KMaterial Agreement · Agreement TerminatedMar 18, 2024424B5PROSPECTUS SUPPLEMENTMar 18, 202410-KANNUAL REPORTMar 6, 20248-KCompany UpdateFeb 20, 20248-KMaterial AgreementJan 23, 20248-KExecutive ChangeJan 19, 20248-KCompany UpdateDec 21, 20238-KExecutive ChangeDec 18, 202310-QQUARTERLY REPORTNov 9, 20238-KMaterial Agreement · Agreement TerminatedSep 26, 20238-KCompany UpdateSep 13, 20238-KMaterial Agreement · Company UpdateAug 22, 202310-QQUARTERLY REPORTAug 10, 20238-KMaterial AgreementAug 9, 20238-KCompany UpdateAug 7, 20238-KShareholder VoteJul 13, 2023DEF 14ADEFINITIVE PROXY STATEMENTMay 31, 202310-QQUARTERLY REPORTMay 11, 20238-KExecutive ChangeMay 1, 202310-KANNUAL REPORTMar 6, 20238-KBylaw AmendmentFeb 27, 20238-KCompany UpdateJan 12, 20238-KReg FD DisclosureDec 12, 20228-KCompany UpdateNov 14, 20228-KResults of OperationsNov 10, 202210-QQUARTERLY REPORTNov 10, 20228-KBylaw AmendmentSep 19, 20228-KCompany UpdateSep 13, 20228-KCompany UpdateSep 8, 202210-QQUARTERLY REPORTAug 10, 20228-KCompany UpdateJul 7, 20228-KShareholder VoteJun 30, 2022DEF 14ADEFINITIVE PROXY STATEMENTJun 2, 202210-QQUARTERLY REPORTMay 12, 2022
Similar companies
Comparable business profile · signals at a glance